Hedge Fund - Scopia Capital

Activist shareholders continue to be closely-monitored and imitated by investors, given their ability to affect positive change at companies.

The handful of hedge fund managers who have a strong record of outperforming broader market benchmarks do not manage capital for the masses.

Matt Sirovich and Jeremy Mindich's Scopia Capital has reported its passive stake in Neuroderm Ltd (NASDAQ:NDRM) via a 13G filing with the Securities and Exchange Commission.

Many believe that the end of the near-zero interest rate era will put some weight on U.S. equities, which might give hedge funds a change to prove their stock picking abilities once again.

Want to invest like an elite hedge fund or become an investor in a hedge fund? Hedge fund investing may be quite expensive if considering the 2-and-2o fee structure most hedge funds use, but one can follow...

Both small and large hedge fund vehicles have filed their latest 13Fs with the SEC, which means that individual investors can now pick potential winners by examining the filings and moves of successful...

The masses may already know that 13D filings are required to be submitted when hedge funds or other money managers have ownership stakes of 5% or more in U.S-listed companies and intend to engage that...

In a joint filing by Jerome Lande and Craig Rosenblum's Coppersmith Capital and Scopia Capital Management, founded by Matt Sirovich and Jeremy Mindich, the duo has disclosed a joint stake of 2.81 million...

A new 13D filing with the SEC discloses that Coppersmith Capital Management, co-founded by its managing partner Jerome Lande, holds an ownership stake of nearly 1.43 million shares in Itron Inc.